---
title: "RXO Q2 2026 adjusted EBITDA falls 5% to $38 million; revenue drops 20% to $1.42 billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295092729.md"
description: "RXO reported Q2 2026 results with revenue dropping 20% to $1.42 billion and adjusted EBITDA falling 5% to $38 million. The company posted a GAAP net loss of $9 million. However, non-GAAP adjusted diluted EPS rose to $0.06 from $0.04. Brokerage volume increased 2% year-over-year. RXO set its Q3 adjusted EBITDA outlook between $35 million and $45 million."
datetime: "2026-08-06T10:41:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295092729.md)
  - [en](https://longbridge.com/en/news/295092729.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295092729.md)
generator: "portal-rs"
---

# RXO Q2 2026 adjusted EBITDA falls 5% to $38 million; revenue drops 20% to $1.42 billion

-   RXO posted Q2 2026 GAAP net loss of $9 million, unchanged from a year earlier; GAAP diluted EPS held at $(0.05). \* Revenue fell 20.01% to $1.42 billion; gross margin slipped 1.98% to $247 million. \* Adjusted EBITDA (non-GAAP) eased 5% to $38 million; adjusted diluted EPS (non-GAAP) rose to $0.06 from $0.04. \* Brokerage volume rose 2% year-over-year, including 2% TL growth; TL spot mix climbed to 42%, up 900 bps sequentially. \* Q3 adjusted EBITDA outlook set at $35 million-$45 million; management said brokerage TL volume improved each month in Q2. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RXO Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [RXO.US](https://longbridge.com/en/quote/RXO.US.md)

## Related News & Research

- [RXO (RXO) Is Up 7.2% After Strong Brokerage Growth Narrows Losses - Has The Bull Case Changed?](https://longbridge.com/en/news/295373080.md)
- [RISK: ARR up 8% and churn at 0%, but extraordinary IT costs drove negative EBITDA in Q2 2026](https://longbridge.com/en/news/296323557.md)
- [SenzaGen restates Q2 EBITDA to SEK -1.2 million in corrected interim report](https://longbridge.com/en/news/296509911.md)
- [NOSA: Q2 2026 saw 81% sales growth, improved EBITDA, and major market expansions](https://longbridge.com/en/news/296576810.md)
- [NORTHM: Q2 2026 saw lower revenue and EBITDA, but net profit surged on investment gains](https://longbridge.com/en/news/296623514.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**